Evidence map›Paper›PMID 36552584›Full record

ReviewAntioxidants (Basel, Switzerland)2022

Nrf2 Regulates Oxidative Stress and Its Role in Cerebral Ischemic Stroke.

Lei Wang, Xu Zhang, Xiaoxing Xiong, Hua Zhu, Ran Chen, Shudi Zhang, Gang Chen, Zhihong Jian

Open access · goldAbstract readReview
In one paragraph

Review in Antioxidants (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 170 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
170citing papers in PubMed, 1 pooled it
23.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

170 citing papers in PubMed, 1 synthesis or guideline pooled it, 299 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Therapeutic potential ofPharmaceutical biology · 2026
    Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

110 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Lei WangDepartment of Neurosurgery, Renmin Hospital of Wuhan University, Wuhan 430060, China.
Xu ZhangDepartment of Neurosurgery, Renmin Hospital of Wuhan University, Wuhan 430060, China.
Xiaoxing XiongDepartment of Neurosurgery, Renmin Hospital of Wuhan University, Wuhan 430060, China.
Hua ZhuDepartment of Neurosurgery, Renmin Hospital of Wuhan University, Wuhan 430060, China.ORCID 0000-0002-3878-2672
Ran ChenDepartment of Neurosurgery, Renmin Hospital of Wuhan University, Wuhan 430060, China.
Shudi ZhangDepartment of Neurosurgery, Renmin Hospital of Wuhan University, Wuhan 430060, China.
Gang ChenDepartment of Neurosurgery, Renmin Hospital of Wuhan University, Wuhan 430060, China.
Zhihong JianDepartment of Neurosurgery, Renmin Hospital of Wuhan University, Wuhan 430060, China.
Wuhan University · CN

Funding

Health Commission of Hubei Province Scientific Research Project WJ2021M148Hubei Province Key Laboratory Open Project 2021KFY044National Natural Science Foundation of China 81870939National Natural Science Foundation of China 82171336
6 · The paper itself

Abstract

Cerebral ischemic stroke is characterized by acute ischemia in a certain part of the brain, which leads to brain cells necrosis, apoptosis, ferroptosis, pyroptosis, etc. At present, there are limited effective clinical treatments for cerebral ischemic stroke, and the recovery of cerebral blood circulation will lead to cerebral ischemia-reperfusion injury (CIRI). Cerebral ischemic stroke involves many pathological processes such as oxidative stress, inflammation, and mitochondrial dysfunction. Nuclear factor erythroid 2-related factor 2 (Nrf2), as one of the most critical antioxidant transcription factors in cells, can coordinate various cytoprotective factors to inhibit oxidative stress. Targeting Nrf2 is considered as a potential strategy to prevent and treat cerebral ischemia injury. During cerebral ischemia, Nrf2 participates in signaling pathways such as Keap1, PI3K/AKT, MAPK, NF-κB, and HO-1, and then alleviates cerebral ischemia injury or CIRI by inhibiting oxidative stress, anti-inflammation, maintaining mitochondrial homeostasis, protecting the blood-brain barrier, and inhibiting ferroptosis. In this review, we have discussed the structure of Nrf2, the mechanisms of Nrf2 in cerebral ischemic stroke, the related research on the treatment of cerebral ischemia through the Nrf2 signaling pathway in recent years, and expounded the important role and future potential of the Nrf2 pathway in cerebral ischemic stroke.

Indexed as

blood–brain barriercerebral ischemic strokeferroptosisinflammationmitochondrial functionNrf2oxidative stress

Identifiers

PMID36552584
PMCPMC9774301
OpenAlexW4310396520

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.